Search

Phenoxazines have gained enormous interest because of their diverse applications in both material science and chemotherapy. They exhibit numerous biological activities, ranging from anti‐malarial, anticancer, antiviral, antidiabetic, anti‐Alzheimer, antioxidant, anti‐inflammatory, to antibiotic and many more. Actinomycin D, for instance, which embodies a phenoxazine scaffold, displays both antibiotic and anticancer property. Phenoxaxines have also found usefulness in organic light‐emitting diodes, fluorescent probes and dye‐sensitized solar cells. Over the years, various research groups have strived for several structural modifications targeting new derivatives of phenoxazines with improved properties. This present review highlights the progress, challenges and prospects in medicinal and material applications of phenoxazine moiety to provide greater insight into the development of future derivatives with improved properties. [ABSTRACT FROM AUTHOR]

Some derivatives of phenothiazine and phenoxazine compounds were synthesized via Hiyama‐cross coupling reaction protocol. The intermediates were prepared by reacting 2‐aminothiophenol, 2‐aminopyridin‐3‐ol and 4,5‐diamino‐6‐hydroxylpyrimidin‐2‐thiol with 2,3‐dibromonaphthalene‐1,4‐dione in alkaline medium of anhydrous sodium carbonate. These intermediates were subjected to the fluoride‐free Hiyama cross‐coupling reaction with 2‐(dimethylsilyl)pyridine and dimethyl(2‐thienyl)silanol using magnetically separable Pd/Fe3O4 as the catalyst under aqueous conditions to yield the derivatives. Molecular descriptors of these compounds were evaluated for their drug‐likeness. Pharmacokinetic parameters were also evaluated. Molecular docking studies were performed. The synthesized compounds showed drug‐likeness. Pharmacokinetic evaluation reveals a strong plasma protein binding and potentials to cross blood‐brain barrier. 6‐(Thiophen‐2‐yl)‐5H‐11‐azabenzo[a]phenoxazin‐5‐one (8 b) and 11‐Amino‐9‐thio‐6‐(thiophen‐2‐yl)‐5H‐8,11‐diazabenzo[a]phenoxazin‐5‐one (9 b) showed highest binding energies of −5.74 and −7.25 kcal/mol with the protein targets glucosamine‐6‐phosphate synthase (2VF5) and lanosterol‐14α‐demethylase (3JUV) respectively. The phenoxazines synthesized were found to be potential inhibitors of glucosamine‐6‐phosphate synthase and lanosterol‐14α‐demethylase. [ABSTRACT FROM AUTHOR]